Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. - Wikidata - awgldk - TriplyDB

Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.

Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.

http://www.wikidata.org/entity/Q37625238

about

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Antimicrobial drug resistance in Singapore hospitals.Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.Management of healthcare-associated methicillin-resistant Staphylococcus aureus.Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients.Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals Antimicrobial resistance in Asia: current epidemiology and clinical implications Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling.Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong.Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.Evaluation of Tigecycline Activity Against Methicillin-Resistante Staphylococcus aureus Isolated from Biological Samples.Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study Statistical optimization of a multivariate fermentation process for enhancing antibiotic activity of Streptomyces sp. CS392.First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary.Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells.

P2860

Q24646677-955D91A9-FB4C-4ADF-BF1C-2BA92A24FB22 Q26796560-73286339-B70C-488A-9CA5-98ADAE22D2DA Q33261667-67DE775F-E718-46D2-9665-07B23EE005AA Q33696380-60E476A9-F65E-46E9-90A9-0563D2CC5A7C Q33877777-8973AA2E-5DCF-4656-B003-BF2B57450984 Q34998629-E7B15EA4-5F7B-465E-BF69-4CFD25731CE1 Q36322109-2875C5BF-9405-4330-B7F4-32915C516D18 Q36363012-DB91AB5E-57EE-43A2-AD89-C01DF299B137 Q36636699-514E9F78-734A-4DBF-9FFC-8D03A2CDD898 Q36876054-595F1E23-4E46-4323-AF01-A97F396765FB Q37192102-CA540547-DEEF-4618-A131-9EF01D648F52 Q37333104-29698CB1-7B9C-4BAF-9B13-8D2A801FD3F7 Q37482046-7150DE2D-2660-46D0-A34C-16310DD93D37 Q37809666-447C6665-F861-4747-BAEE-1A986A2E102E Q39732185-FFE3CF2D-C5E4-49A7-B3FD-F337AB338EEA Q41066970-EE4903B7-063E-4ACF-80F9-54CB0A99ED89 Q42781919-702844DD-6112-44D1-8FFA-22FF7F13B71E Q43694841-A619C52E-F930-47AF-BCA5-B21C5FF01FD5 Q44340623-509D2C49-45F0-4EBE-887F-C64DB55A4A05 Q46231655-58421024-2B73-4198-9CD8-9BE6506F417E Q46691212-9C1FE792-70D1-4A5D-BEA4-3EB31967DD15

P2860

Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.

http://www.wikidata.org/entity/Q37625238

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emergence in Asian countries o ...... susceptibility to vancomycin.

@en

Emergence in Asian countries o ...... susceptibility to vancomycin.

@nl

type

label

Emergence in Asian countries o ...... susceptibility to vancomycin.

@en

Emergence in Asian countries o ...... susceptibility to vancomycin.

@nl

prefLabel

Emergence in Asian countries o ...... susceptibility to vancomycin.

@en

Emergence in Asian countries o ...... susceptibility to vancomycin.

@nl

P1433

Q37625238-D69783A0-4243-4C75-8A6B-31D7B0C760AD

P1476

Q37625238-EB810484-8762-4C36-B4C6-1D6FB3E3FF9C

P2093

Q37625238-0C4CBEC1-D5B4-4811-8260-EF4436769F98

Q37625238-3565BBA9-3448-4A75-A3C3-46CABF7D68FC

Q37625238-3F52C54B-EB3E-415A-A695-30A0AD78E715

Q37625238-5C2071A3-4CDF-4D34-A7BB-1778C9ABB6A6

Q37625238-7DB818FF-0137-4E4A-895F-093571AF04F5

Q37625238-859A898C-F217-4614-93E7-6973D02F3EB9

Q37625238-86323433-69F2-4F95-87E4-22A4F7BB29CA

Q37625238-B3F84F48-DE2E-49DF-B031-B26E9060391A

Q37625238-BC2E02C2-0D03-4ACF-99D3-68B8CDDA21C1

Q37625238-DADE5EE1-C788-443C-86AE-08340B550E18

P2860

Q37625238-1900E30C-BEF4-466F-87B6-97C5A5420591

Q37625238-2387661C-79ED-4DB2-AE36-01DC53A389AF

Q37625238-2DEEFC91-D04E-44D6-8E2F-97975B2F0119

Q37625238-45A2A2E6-E6A6-4E98-BD7A-E8F472C42294

Q37625238-4D7B3A2A-B923-40FC-A10B-7C2128631A42

Q37625238-538147BB-F619-4284-A674-73F31DE90577

Q37625238-582AA8DF-0742-4B64-A8F0-E6C137872C8A

Q37625238-5EEDBE3A-4A04-4390-BCD9-B17C0CFD9535

Q37625238-6007EE50-577A-40C5-80F9-A7D63F817BBD

Q37625238-670B93BE-79C9-4FF8-9A5E-B3B3C4A4A8B8

P304

Q37625238-660F605D-0EDD-403F-B1E6-FF79FA301F52

P31

Q37625238-99F8FA03-20AD-4702-B320-88CFAAB86F48

P356

Q37625238-4E78F500-F7C5-435D-8825-7A42A6CA1D88

P407

Q37625238-4656F85F-B206-4126-B052-4107C7A26086

P433

Q37625238-4B064EEE-AF0C-4D7F-9090-BFA39300BC00

P478

Q37625238-BA1CD64E-9C0C-4B7D-9FC5-F4E008CD40CD

P50

Q37625238-91C76075-480E-4F25-B9E7-0184FB519EB0

Q37625238-A676CDEF-27EA-4760-BD02-571C25BC5C65

P577

Q37625238-C831439F-4A64-45F1-A62F-906B105C1EBB

P698

Q37625238-5D2B586B-4D4C-4DC4-8707-ED69D4B8C2AA

P932

Q37625238-CDD21BE0-FC1A-422E-97B8-098B9E4EF41D

P356

AAC.48.12.4926-4928.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

Emergence in Asian countries o ...... d susceptibility to vancomycin

@en

P2093

Asian Network for Surveillance of Resistant Pathogens Study Group

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Song

http://www.w3.org/2001/XMLSchema#string

Ji Yoeun Suh

http://www.w3.org/2001/XMLSchema#string

Keiichi Hiramatsu

http://www.w3.org/2001/XMLSchema#string

Kwan Soo Ko

http://www.w3.org/2001/XMLSchema#string

Kyong Ran Peck

http://www.w3.org/2001/XMLSchema#string

Maria Kapi

http://www.w3.org/2001/XMLSchema#string

Nam Yong Lee

http://www.w3.org/2001/XMLSchema#string

Sungmin Kiem

http://www.w3.org/2001/XMLSchema#string

Teruyo Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Vancomycin-intermediate Staphylococcus aureus in Korea.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.

Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients.

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

P304

4926-4928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.12.4926-4928.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15561884

http://www.w3.org/2001/XMLSchema#string

P932

529235

http://www.w3.org/2001/XMLSchema#string